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Background
It was reported that the occurrence of myocardial fibro-
sis was related to sudden cardiac death and heart failure
in patients with HCM. Late gadolinium enhancement
(LGE) magnetic resonance imaging (MRI) is a widely
used clinical method to detect fibrosis, however, its spa-
tial resolution is limited. The purpose of this feasibility
study is to determine the value of T1 mapping for the
non-invasive assessment of myocardial fibrosis in
patients with hypertrophic cardiomyopathy (HCM).
Methods
Thirty HCM patients and 20 healthy volunteers under-
went conventional late gadolinium enhancement (LGE)
imaging and T1 mapping (Siemens prototype sequence)
on a clinical 1.5T scanner (MAGNETOM Aera, Siemens
Healthcare). T1 mapping was performed with a modified
look-locker inversion-recovery (MOLLI) sequence
acquired during breath hold in the same planes after
LGE imaging. Typical imaging parameters were: non-
selective inversion pulse, steady-state free precession sin-
gle-shot read out in mid-diastole, FOV of 360 × 250 mm2,
matrix of 192 × 150, slice thickness of 8 mm, TR/TE of
375.28/1.01 ms, minimum inversion time of 90 ms, inver-
sion time increment of 80 ms, FA of 35?, PAT factor of
2, number of inversions 2, images acquired after first
inversion 3, pause 3 heart beats, and images acquired after
second inversion. T1 Mapping was used for measurement
of T1 values. Global ECV values were calculated from T1
maps acquired pre- and post-contrast calibrated by blood
hematocrit. The extracellular volume (ECV) value was cal-
culated as: ECV = (1-hematocrit) (1/T1myopost-1/
T1myopre) / (1/T1bloodpost-1/T1bloodpre).
Results
HCM patients had the same age as control group
(38.2 ± 18.5 vs. 34.8 ± 15.7, P=NS). Pre-contrast myo-
cardial T1 time and myocardial ECV in patients with
HCM was significantly higher than the measurement in
control cases, and post-contrast myocardial T1 time in
HCM patients was significantly lower than that in con-
trol cases (P < 0.05, respectively) (Table 1, Figure 1).
Conclusions
The MOLLI T1 mapping used in the present study has
combined the fast acquisition time and multiple contrast
capabilities of the TI scout with the improved CNR, spa-
tial resolution, and spatial coverage of the segmented IR
LGE scans. The combination reduces the total imaging
time, enables T1 quantification, and does not compro-
mise image quality. A relatively higher pre-contrast T1
value and ECV, and lower post-contrast T1 value were
found with T1 mapping in the myocardium of HCM
patients, which suggested T1 mapping is better in the
evaluation of myocardial fibrosis. The main limitation is
that we had a small patient population without sub-
group analysis and follow-up.
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Table 1 T1 measurement and ECV in cases with HCM and
in control cases
Mapping parameters HCM Control P value
Pre-contrast T1 value 1217.3 ± 97.4 1143.6 ± 84.3 0.021
Post-contrast T1 value 489.3 ± 57.1 503.1 ± 64.4 0.016
ECV 0.257 ± 0.036 0.231 ± 0.028 0.009
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